CCC model to help serious illness conversations and care in cancer
Official title: Evaluating the Effectiveness, Acceptability and Feasibility of a Communication and Care Coordinator (CCC) Model in Facilitating Serious Illness Communication (SIC) and Care in Patients With Cancer
Run by National Cancer Centre, Singapore · NCT07733973 · Data updated 2026-11-12
This trial tests a Communication and Care Coordinator (CCC) model to see if it can improve communication about serious illness and care planning for cancer patients.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years and up |
| Sex | All |
| Enrollment | 560 (estimated) |
| Sponsor | National Cancer Centre, Singapore Academic / other |
| Locations | 1 site (Singapore) |
| Status | Recruiting |
| Started | November 5, 2026 |
| Main results expected | June 30, 2028 |
| Study ends | June 30, 2029 |
| Registry record updated | November 10, 2026 |
| Trial ID | NCT07733973 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 21 or older with advanced cancer or high-risk recurrence, able to speak English or Chinese, treated by NCCS oncologists of associate consultant level or higher.
✕Probably not a fit
Patients who prefer standard care or who are not candidates for enhanced communication support may not experience additional benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study uses a stepped wedge cluster randomized design at a national cancer center to compare the CCC intervention with usual care. It aims to determine whether the CCC model improves patient outcomes, increases documentation of serious illness conversations and advance care planning, and is acceptable to patients and clinicians. The intervention deploys dedicated coordinators to support oncology teams in facilitating timely, patient-centered communication about goals of care. Outcomes include feasibility of implementation and potential impact on patient well-being and care documentation. Enrollment includes adults with advanced or high-risk cancer who can speak English or Chinese, with participating oncologists at NCC Singapore.
Why it matters
Potential benefit: If successful, the CCC model could enable more timely and meaningful conversations about goals of care and improve documentation and care aligned with patient preferences.
How similar studies have gone: Previous work in similar coordination models has shown promise in improving communication and planning, but this specific CCC approach in Singapore is novel and exploratory.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Patient Participants * Aged 21 and above * Diagnosed with (a) advanced cancer (stage 3 or 4) or (b) non-advanced cancer, but at high risk of recurrence * Able to speak English or Chinese, irrespective of race Clinicians * Oncologists who are at least of designation of associate consultant and above in NCCS Exclusion Criteria: Patient Participants * Disoriented and thus not able to sign informed consent * Diagnosed with untreated hearing or visual loss or psychiatric illness * Active suicidal ideation Clinicians * Overseas/not practising in Singapore for a significant amount of time
Where it's running
-
National Cancer Center, Singapore
Singapore, Singapore Recruiting
Study contacts
- Study coordinator: Shirlyn NEO Hui Shan, MD, PhD
- Email: shirlyn.neo.h.s@singhealth.com.sg
- Phone: 63065838
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI chatbot to screen for hereditary cancer risk in Singaporeans
A chat-based AI tool is being tested to see if it can quickly and reliably flag people who may have hereditary cancer risk.
-
Histotripsy treatment for small liver tumours in Asia
This trial will try using histotripsy, a noninvasive focused-ultrasound treatment, to destroy small liver tumors in adults in Asia who are not candidates for surgery or other local therapies.
-
Aromatherapy for Mild Cognitive Impairment and Mild Dementia
This study tests whether a diffused essential-oil blend for 6 months can help reduce symptoms for people with MCI or mild dementia and lessen caregiver stress.
-
Exercise plus cognitive behavioural therapy for fatigue in women treated for breast cancer in Singapore
This program tests whether graded exercise combined with cognitive behavioural therapy can reduce fatigue and help women with breast cancer stay on their treatment plans.
-
iCareBreast+: a smartphone self-care app for women with breast cancer on chemotherapy
This pilot tests whether iCareBreast+, a smartphone self-care app, helps women with stage 1–3 breast cancer who are starting chemotherapy feel more confident, informed, and better able to manage symptoms.
-
Assessing outcomes in patients with advanced solid tumors receiving non-standard therapies
This study is testing how well non-standard treatments work for patients with advanced solid tumors by using personalized treatment plans based on their unique genetic profiles.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.